|1.||Odom, Terri: 1 article (12/2015)|
|2.||Yamamoto-Furusho, Jesús K: 1 article (12/2015)|
|3.||Barnes, Michael E: 1 article (12/2015)|
|4.||Sarmiento Aguilar, Andrea: 1 article (12/2015)|
|5.||Woodland, Malcolm H: 1 article (12/2015)|
|6.||Andretta, James R: 1 article (12/2015)|
|7.||Roberson-Adams, Shelia: 1 article (12/2015)|
|8.||Ramirez, Aaron M: 1 article (12/2015)|
|9.||Shulman, Abraham: 1 article (01/2012)|
|10.||Marchbanks, Robert J: 1 article (01/2012)|
|1.||Coronary Artery Disease (Coronary Atherosclerosis)
04/01/1994 - "Iodine-123-phenylpentadecanoic acid (IPPA) is a synthetic radiolabeled fatty acid that has shown promise in evaluating patients with coronary artery disease (CAD). "
03/01/1995 - "This study examined the ability of dynamic 123I-labeled iodophenylpentadecanoic acid (IPPA) imaging to detect myocardial viability in patients with left ventricular (LV) dysfunction caused by coronary artery disease. "
04/01/1994 - "Initial research in dogs and later research in normal volunteers and patients with coronary artery disease indicated that 123I-iodophenylpentadecanoic acid (IPPA) can provide valuable diagnostic information. "
01/01/1992 - "To characterise the clinical usefulness of serial myocardial scintigraphy with iodine-123 phenylpentadecanoic acid (IPPA) in comparison with thallium-201, dual-isotope investigations were performed in 41 patients with angiographically documented coronary artery disease. "
11/01/1988 - "In 15 normal subjects and 30 patients with coronary artery disease, 201Tl and 15-(p-123I-iodophenyl)-pentadecanoic acid (IPPA) were administered during exercise under fasting conditions and at rest. "
|2.||Myocardial Ischemia (Ischemic Heart Diseases)
06/01/1990 - "The postexercise heterogeneity in IPPA uptake and delayed washout in segments with reduced initial uptake is consistent with exercise-induced myocardial ischemia in patients with LVH."
01/01/1990 - "We conclude that [123I]IPPA is a useful indicator of developing myocardial ischemia."
01/01/1990 - "Imaging 123I-labeled iodophenylpentadecanoic acid (IPPA) uptake and clearance from the myocardium following exercise has been advocated as a means of detecting myocardial ischemia because fatty acid deposition is enhanced and clearance prolonged in regions of low flow. "
11/01/1988 - "The radioidinated synthetic fatty acid iodine-123 phenylpentadecanoic acid (IPPA) has proven useful in the identification of regional abnormalities of cardiac metabolism in patients with myocardial ischemia. "
11/01/1986 - "In this study, we tested the hypothesis that myocardial ischemia induced by exercise in patients is associated with diminished metabolism and/or delayed clearance of an intravenously injected fatty acid, iodine 123-labeled phenylpentadecanoic acid (IPPA). "
03/01/2002 - "This study evaluated the potential of dynamic SPECT imaging of a FFA analog, p-(123)I-iodophenylpentadecanoic acid (IPPA), for detection of ischemia and compares retention of IPPA with (18)F-FDG accumulation. "
03/01/2002 - "In a canine model of regional low-flow ischemia (n = 9), serial IPPA SPECT images (2 min per image) were acquired over 52--90 min. In a subset of dogs (n = 6), (18)F-FDG was injected after completing SPECT imaging and allowed to accumulate for 40 min before killing the animals. "
04/01/1989 - "These findings indicate reduced cardiac utilization and delayed oxidation of IPPA, associated with exercise-induced ischemia in CAD. "
07/01/1988 - "The second hypothesis tested was that IPPA imaging is as or more sensitive and, therefore, complementary to thallium-201 imaging in the identification of exercise-induced ischemia in patients. "
01/01/1988 - "Efficacy of 15-(123I)-p-iodophenyl pentadecanoic acid (IPPA) in assessing myocardial metabolism in a model of reversible global ischemia."
|4.||Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
11/01/1988 - "Patients with congestive cardiomyopathy demonstrated significantly greater heterogeneity of IPPA uptake than normal subjects (maximal percent variation of activity 27 +/- 11 vs 18 +/- 4, p less than 0.01). "
06/01/1988 - "In dilated cardiomyopathy (DCM) both IPPA-EF and 201Tl uptake showed distinct regional variations and a great interindividual variability with a mean IPPA-EF reduction of 12% (N = 9). "
11/01/1988 - "Nine normal volunteers and 19 patients with dilated cardiomyopathy of various etiologies underwent cardiac imaging with single-photon emission computed tomography (SPECT) after intravenous injection of IPPA. "
|5.||Coronary Stenosis (Coronary Artery Stenosis)
|3.||Aligeron (AS 2)
|4.||Fatty Acids (Saturated Fatty Acids)
|6.||omega-(4-iodophenyl)pentadecanoic acid (IPPA)
|7.||Palmitic Acid (Hexadecanoic Acid)
|8.||Nitroprusside (Sodium Nitroprusside)
|10.||Acetylcholine (Acetylcholine Chloride)
|1.||Coronary Balloon Angioplasty (Percutaneous Transluminal Coronary Angioplasty)
|2.||Gamma Cameras (Gamma Camera)